Pretreatment preparation and management of interferon-based therapy for hepatitis C virus infection.
OBJECTIVE
This paper is a report of a study to explore how healthcare professionals prepare patients for hepatitis C treatment and the management strategy used during this treatment.


BACKGROUND
A high proportion of patients receiving hepatitis C treatment has dose reductions or discontinues treatment because of adverse events arising from the therapeutic drugs.


METHODS
An exploratory study was carried out in Australia in 2004 and 2005 using semi-structured interviews with a sample of six healthcare professionals with experience in managing hepatitis C treatment regimens.


RESULTS
Participants reported that pretreatment preparation focused on information provision regarding the adverse events and the medical strategies that could ameliorate their impact. Patients' vulnerabilities and supports were assessed prior to treatment and healthcare professionals sought to address patients' problems as they arose during treatment. Participants discussed patients' resilient coping style and the beneficial impact this had on treatment management.


CONCLUSIONS
Among our sample, a deficits-based approach was taken to hepatitis C treatment management. While some attempts were made to assess patients' strengths, these were limited to identifying those in family, work and social networks who could lend support to patients when problems occurred. Exploring patients' past experiences of adversity and making a detailed evaluation of a range of patients' strengths might assist clinicians in managing hepatitis C treatment regimens.
Hopwood
Max
M
National Centre in HIV Social Research, The University of New South Wales, Sydney, Australia. m.hopwood@unsw.edu.au
Treloar
Carla
C
D000223:Adaptation, Psychological; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001291:Attitude of Health Personnel; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000451:nursing*; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use*; D009723:Nurse-Patient Relations; D010353:Patient Education as Topic / Q000379:methods; D011287:Prejudice; D011364:Professional Practice
D000998:Antiviral Agents; D007372:Interferons